The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
13 Feb 2019
Survey on barriers of early diagnosis of cancer
04 Feb 2019
Call for Experts on social inequalities in cancer prevention
FISABIO launches a Call for Experts on social inequalities in cancer prevention to assist with the evaluation of Best Practices in this field.
21 Jan 2019
WP5 Conference on Early Detection
The WP5 Conference on Early Detection will take place on 20 May 2019 and will be hosted by the Hungarian National Institute of Oncology in Budapest.
18 Jan 2019
iPAAC Local Stakeholder Forum in Malta
The Maltese Stakeholder Forum was held on 14 and 15 January 2019 at the Sir Anthony Mamo Oncology Centre.